This Award Notice opportunity from Department Of Defense was posted on July 11, 2026. The submission period has ended. Browse the details below for market research, or find similar active opportunities.

Top

OMEPRAZOLE EXTENDED-RELEASE CAPSULES

Awarded

SPE2DP26F7351Federal

Contract Overview

Solicitation details, issuing organization, response deadlines, documents, and interested companies for this government contract opportunity.

Active Opportunities Like This One

NAICS: 325412

New

DIBBS

Hydrogen Peroxide Topical Solution SupplierThis subcontract involves the supply of 3% strength Hydrogen Peroxide Topical Solution for prime contractors supporting Department of Defense projects under the Medical Supply Chain Pharm FSA. The supplier is responsible for manufacturing or sourcing the liquid solution in 4-ounce bottles, delivered in cases of 24. Strict quality and storage requirements are mandated, including maintaining a temperature between 20 and 25 degrees Celsius and ensuring a minimum shelf life of 21 months upon receipt. The contractor must adhere to OTC pharmaceutical standards, the Buy American Act, the Berry Amendment, and Medical Marking Standard No. 1. Performance for this contract is centered in Fort Hood, Texas, under NAICS code 325412. Interested parties must have responded by the deadline of November 18, 2026.

MEDICAL SUPPLY CHAIN PHARM FSA

POSTED

DEADLINE

Salicylic Acid Gel SupplierThis subcontract through the Department of Defense Medical Supply Chain Pharm FSA requires the provision of 12,000 tubes of medical-grade Salicylic Acid Gel with a 17 percent concentration. Each tube must contain 0.25 ounces of the gel and be manufactured or sourced to meet strict storage and transport requirements at medical controlled room temperature. The supplier must ensure all products adhere to Medical Marking Standard No. 1 and follow packaging guidelines established by MIL-STD-129 and MIL-STD-2073-1E. Additionally, all shipments must include hazard warning labels in compliance with 252.223-7001 to support prime contractors delivering essential medical supplies to DLA Troop Support.

MEDICAL SUPPLY CHAIN PHARM FSA

POSTED

DEADLINE

Loratadine Tablets 10 MG SupplierThis subcontract involves the supply of FDA-regulated Loratadine Tablets 10 MG for the Department of Defense under MEDICAL SUPPLY CHAIN PHARM FSA projects. The supplier is responsible for providing 2,000 bottles of 500-count Type I Code Q tablets, which must be produced in FDA-approved facilities and comply with the Buy American Act. The tablets must have a non-extendable shelf life of 36 months and be stored in a climate-controlled environment between 20 and 25 degrees Celsius. The performance of this contract will take place at Fort Campbell, Kentucky. Interested parties should note that the response deadline is November 18, 2026, and the requirement falls under NAICS code 325412.

MEDICAL SUPPLY CHAIN PHARM FSA

POSTED

DEADLINE

Veterinary Combination Otic Ointment ManufacturerThis subcontract opportunity is for the formulation and manufacture of a specialized veterinary combination otic ointment for the Department of Defense Medical Supply Chain Pharm FSA. The required product must contain Gentamicin base, Betamethasone Valerate, and Clotrimazole, packaged in 15g tubes with a minimum shelf life of 24 months. The manufacturer is responsible for delivering one package of the specified ointment to Fort Bragg. To qualify for this contract, the provider must hold FDA manufacturing certification and strictly adhere to Good Manufacturing Practices. The solicitation was posted on November 12, 2026, with a response deadline of November 18, 2026. This project falls under NAICS code 325412 and supports prime contractors operating within the DLA Troop Support framework.

MEDICAL SUPPLY CHAIN PHARM FSA

POSTED

DEADLINE

Supply of Medical Material NSN 6505011893973This subcontract involves the procurement and delivery of medical material identified by NSN 6505011893973 to support prime contractors for the Department of Defense Medical Supply Chain Pharm FSA. The selected provider is responsible for ensuring all materials are packaged according to ASTM D3951 or TQ Requirement IP025 and marked in accordance with Medical Marking Standard No. 1, while maintaining full compliance with FED-STD-313 and MIL-STD-129. The contract is categorized under NAICS code 325412 and requires delivery on a FOB Destination basis to FPO 96670. Interested parties must submit their responses by November 17, 2026, to meet the requirements of this medical supply chain operation.

MEDICAL SUPPLY CHAIN PHARM FSA

POSTED

DEADLINE

Supply of Bupivacaine and Epinephrine InjectionThis subcontract involves the procurement and delivery of Bupivacaine and Epinephrine injections to support prime contractors under the Department of Defense Medical Supply Chain Pharm FSA. The supplier is responsible for ensuring all pharmaceutical injections are packaged according to ASTM D3951 or TQ Requirement IP025 and marked in accordance with Medical Marking Standard No. 1. Additionally, all shipments must comply with FED-STD-313 and MIL-STD-129 standards, with a mandatory minimum shelf life of 15 months upon delivery. The contract is categorized under NAICS code 325412 and specifies that delivery terms are FOB Destination, with the place of performance located at FPO 96670. Interested parties should note the response deadline of November 17, 2026, for this Department of Defense requirement.

MEDICAL SUPPLY CHAIN PHARM FSA

POSTED

DEADLINE

Bismuth Subsalicylate Tablet SupplyThis subcontract with the Department of Defense Medical Supply Chain Pharm FSA involves the manufacture and supply of Bismuth Subsalicylate tablets for prime contractors on DLA supply contracts. The provider is responsible for sourcing pharmaceutical products that adhere to the DLA Master List of Technical and Quality Requirements and ensuring all tablets are packaged in units of 48 individually sealed tablets according to RP001 DLA Packaging Requirements. To maintain product integrity, the contractor must utilize climate-controlled storage to ensure temperatures do not exceed 104 degrees Fahrenheit. The scope of work concludes with the delivery of the completed and packaged pharmaceutical tablets to designated government locations, with the place of performance situated at Fort Bliss.

MEDICAL SUPPLY CHAIN PHARM FSA

POSTED

DEADLINE

Levofloxacin 750mg Tablet SupplyThis subcontract involves the supply of prescription-grade Levofloxacin 750mg tablets to prime contractors supporting the Department of Defense Medical Supply Chain Pharm FSA. The provider is responsible for manufacturing or sourcing the medication, which must be delivered in bottles of 20 tablets. Strict adherence to quality standards is required, including FDA-approved packaging, labeling according to Medical Marking Standard No. 1, and a guaranteed shelf life of 24 months. To maintain product integrity, the tablets must be kept in temperature-controlled storage between 20 and 25 degrees Celsius. The performance of this contract is centered in Beaufort, South Carolina, under NAICS code 325412. Interested parties must have responded by the deadline of November 18, 2026.

MEDICAL SUPPLY CHAIN PHARM FSA

POSTED

DEADLINE

Supply of Povidone-Iodine Topical SolutionThis subcontract with the Department of Defense Medical Supply Chain Pharm FSA involves the manufacture or sourcing of Povidone-Iodine Topical Solution, USP, to support prime contractors delivering DLA supply contracts. The required product is a 10 percent concentration solution packaged in 4 FL OZ bottles under NSN 6505-01-0672812. All deliverables must strictly adhere to United States Pharmacopeia standards and meet specific bottling requirements. The contractor is responsible for ensuring that all hazardous materials are packaged in accordance with FED-STD-313 and TQ requirement IP025. Performance for this contract is centered at Fort Bragg, zip code 28310. The solicitation was posted on November 12, 2026, with a response deadline of November 18, 2026, falling under NAICS code 325412.

MEDICAL SUPPLY CHAIN PHARM FSA

POSTED

DEADLINE

Benzocaine and Menthol Lozenge SupplyThis subcontract involves the manufacture and supply of specialized pharmaceutical lozenges containing Benzocaine and Menthol for prime contractors supporting the Defense Logistics Agency. The selected provider is responsible for sourcing or producing lozenges that adhere to specific NSN/FSC requirements and delivering them in PG units. All products must strictly comply with pharmaceutical manufacturing standards and the DLA Master Solicitation Technical and Quality Requirements. Managed by the Medical Supply Chain Pharm FSA under the Department of Defense, the contract is categorized under NAICS code 325412. Performance for this requirement is centered at Fort Bragg, with a response deadline set for November 18, 2026. The primary objective is the consistent delivery of completed pharmaceutical packages that meet all federal quality and technical specifications.

MEDICAL SUPPLY CHAIN PHARM FSA

POSTED

DEADLINE

Supply of Nystatin, Neomycin Sulfate, Thiostreampton & Triamcinolone Acetonide Topical OintmentThis subcontract involves the supply of Nystatin, Neomycin Sulfate, Thiostreampton, and Triamcinolone Acetonide topical ointment for prime contractors supporting Department of Defense DLA Troop Support medical supply contracts. The scope of work includes the formulation, compounding of active pharmaceutical ingredients, and filling of the ointment into 7.5ML tubes. All products must be delivered with a minimum shelf life of 30 months and produced in FDA-approved manufacturing facilities using pharmaceutical-grade mixing equipment. Performance of this contract requires strict adherence to Medical Marking Standard No. 1, MIL-STD-2073-1E, and 29 CFR 1910.1200. The work is associated with NAICS code 325412 and is managed by the Medical Supply Chain Pharm FSA. The designated place of performance is Fort Bragg, North Carolina.

MEDICAL SUPPLY CHAIN PHARM FSA

POSTED

DEADLINE

Specialized Medical Tubing and Component SupplyThis subcontract involves the supply of raw materials and specialized components for prime contractors supporting DLA Troop Support Medical Supply Chain projects. The scope of work focuses on the delivery of bulk medical components to the assembler, specifically including medical-grade tubing with a 0.120 inch internal diameter, micron filters, drip chambers, blood bulb pumps, and roller clamps. To ensure safety and quality, all provided materials must adhere to strict biocompatibility and FDA material compliance standards. Additionally, the supplier is required to maintain ISO 13485 quality management systems. The performance of this contract is centered at Fort Campbell, supporting the Department of Defense.

MEDICAL SUPPLY CHAIN MD SURG FSF

POSTED

about 7 hours ago

DEADLINE

in 6 days

AI Contract Overview

The Defense Logistics Agency has awarded DMS PHARMACEUTICAL GROUP INC under contract SPE2DP26F7351 for the delivery of OMEPRAZOLE EXTENDED-RELEASE CAPSULES, identified by NSN 6505016247068 and PR 7017471541. The total contract value is $203.20, with an award date of July 11, 2026, and the order is placed under the underlying contract SPE2DX25D9900. The awardee, identified by CAGE code 1UNB0, is a federal supplier providing pharmaceutical products to the Department of Defense. The contract details indicate no set-aside classification or NAICS code has been assigned, and the point of contact and performance location information are unspecified. All documentation and ordering details are accessible through the DIBBS portal using the provided UI link.

General Info

DMS PHARMACEUTICAL GROUP to deliver omeprazole capsules for $203.20 under DLA contract SPE2DP26F7351.

Agency

Department Of Defense → Defense Logistics Agency

Contract Value

$203.2

NAICS

325412 - Pharmaceutical Preparation Manufacturing

Place of Performance

IL, USA

Set-Aside

NONE

Awardee

DMS PHARMACEUTICAL GROUP INC

Award Issued Date

07/11/2026, 12:00:00 AM UTC

Documents

award

High

task-order-award

Low

AI Contract Breakdown

Uniform Contract Format

Contract not broken down yet

CLEATUS splits the solicitation into Uniform Contract Format (UCF) sections: scope, pricing, deliverables, and evaluation criteria.

Timeline

PhaseAwarded

PostedJul 11

Award Notice

AwardedJul 11

Contract was awarded

Find active opportunities like this

Get full access to discover similar active contracts, track opportunities, and build proposals with AI assistance.

Organization & Contact Information

AgencyDepartment Of Defense → Defense Logistics Agency

ContactsNo contacts available

OfficeUSA

Organization / AgencyDepartment Of Defense → Defense Logistics Agency

Office AddressUSA

ContactsNo contact information available

Full Description

DLA award SPE2DP26F7351 posted on DIBBS. Awardee: DMS PHARMACEUTICAL GROUP INC (CAGE 1UNB0) Total Contract Price: $203.20 Award Date: 07-11-2026 Delivery order under: SPE2DX25D9900 Line items: - OMEPRAZOLE EXTENDED-RELEASE CAPSULES (NSN/Part 6505016247068, PR 7017471541)